Comparison of interleukin-2-inducible kinase (ITK) inhibitors and potential for combination therapies for T-cell lymphoma.

Saved in:
Bibliographic Details
Title: Comparison of interleukin-2-inducible kinase (ITK) inhibitors and potential for combination therapies for T-cell lymphoma.
Authors: Mamand, Sami1 (AUTHOR), Allchin, Rebecca L.1 (AUTHOR), Ahearne, Matthew J.1 (AUTHOR), Wagner, Simon D.1 (AUTHOR) sw227@le.ac.uk
Source: Scientific Reports. 9/21/2018, Vol. 8 Issue 1, p1-15. 15p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:20452322
DOI:10.1038/s41598-018-32634-5